A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07235384 · RECRUITING
Trial details
- NCT number
- NCT07235384
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-12-28
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.